IP Library Granted Patent US 9,173,994
Granted Patent B2
US 9,173,994 · App. 13/214,990 · Granted Nov 3, 2015

Touch-actuated micropump for transdermal drug delivery and method of use

Inventors: Babak Ziaie (West Lafayette, IN); Manuel Ochoa (West Lafayette, IN); Charilaos Mousoulis (West Lafayette, IN)
Assignee: PURDUE RESEARCH FOUNDATION
A61M5/14248A61M5/14586A61M5/14593A61M2037/003A61M2037/0023
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,173,994
App. No.
13/214,990
Granted
Nov 3, 2015
Kind
B2
Abstract

A micropump device. The micropump device includes a first layer forming a first chamber configured to store a working material, a second chamber defined by a deflectable membrane in fluid communication with the first chamber and configured to deflect in response to a pressure increase in the first chamber in response to a volume increase in the first chamber, the second chamber configured to store a drug compound to be delivered to a subject's vascular system, and at least one needle in fluid communication with the second chamber and configured to penetrate a subject's skin to pump the drug compound in response to the deflection of the deflectable membrane.

Claims (15)

1. A micropump device, comprising:

a first layer forming a first chamber storing a working material;

a second chamber defined by a deflectable membrane separating the second chamber from the first chamber and configured to deflect in response to a volume increase in the first chamber, the second chamber storing a drug compound to be delivered to a subject's vascular system; and

at least one needle in fluid communication with the second chamber and configured to penetrate a subject's skin to pump the drug compound in response to deflection of the deflectable membrane;

wherein the working material in the first chamber is a phase-change material that increases in volume in response to application of heat from a user's skin to the first layer,

the deflectable membrane in fluid contact with the phase-change material in the first chamber and in fluid contact with the drug compound in the second chamber.

2. The micropump of claim 1 , wherein the working material in the first chamber contains a mixture of yeast and a water-based sugar solution.

3. The micropump of claim 1 , wherein the first layer and a material defining the second chamber are made of composite material.

4. The micropump of claim 3 , wherein the composite material is polydimethylsiloxane.

5. The micropump of claim 1 , further comprising:

a third chamber formed by a cap layer and in fluid communication with the second chamber, the third chamber configured to support and provide fluid communication to a plurality of needles; and

at least one channel formed between the second chamber and the third chamber for delivery of the drug compound from the second chamber to the third chamber.

6. The micropump of claim 1 , wherein the first layer is i) formed of a thermally conductive substrate, or ii) in contact with a thermally conductive substrate.

7. The micropump of claim 6 , wherein material of each of the thermally conductive substrates is one of a metal and silicon.

8. The micropump of claim 1 , wherein the volume increase in the first chamber is at a rate of between 33.7 μL/min and 60.1 μL/min.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2012
From: ZIAIE, BABAK; MOUSOULIS, CHARILAOS; OCHOA, MANUEL P.
To: PURDUE RESEARCH FOUNDATION
Reel/Frame 027520/0623 →
CONFIRMATORY LICENSE Recorded Dec 29, 2011
From: PURDUE UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 027464/0152 →
Continuity (3)
Provisional Application 61375575 · Aug 20, 2010
Provisional Application 61406875 · Oct 26, 2010
Related Publication 20120046644A1 · Feb 23, 2012